TrialJournal of immunology (Baltimore, Md. : 1950)2018

Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.

Georg Aue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.